Phase 3 trial evaluating the efficacy and safety of odronextamab plus chemotherapy versus rituximab plus chemotherapy in previously untreated follicular lymphoma (OLYMPIA-2).

Hardin C., Gray C., Novelli S., Hacibekiroglu T., Yagci M., Birhiray R. E., ...Daha Fazla

Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024 identifier

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Ülke: ELECTR NETWORK
  • Gazi Üniversitesi Adresli: Evet